| Strategy | Infection with transmissible pathogen | |||
|---|---|---|---|---|
| Intermittent BCC | Intermittent PA | Chronic PA | Super infection with chronic PA | |
| Cohort segregation | Cost-effectiveness uncertain (dominant to dominated) | Not Cost-Effective (ICER £241,185 to dominated) | Cost-effective (dominant) | NC |
| Protective equipment | Cost-effective (dominant) | Cost-effective (dominant) | NC | NC |
| Single inpatient rooms versus beds in shared rooms | Cost-effective (dominant) | NC | NC | NC |
| Incomplete cohort segregation including en suite bathroom facilities versus no cohort segregation including shared bathroom facilities | NC | Cost-effective if en suite facilities cost less than an additional £21,600/clinic/year | NC | Cost-effectiveness uncertain |
BCC, B cepacia complex; ICER, incremental cost-effectiveness ratio; NC, not calculable; PA, P aeruginosa
From: Appendix K, Health Economics
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.